Signalling caused by PAMPs or their derivatives formed during processing may stimulate innate Toll-like receptors (TLR2 and TLR4), leading to strong immune reactions associated with inflammation, type 2 diabetes, atherosclerosis, and increased cardiometabolic risk factors [84]. The gene discussed is TLR4; the disease is type 2 diabetes mellitus.